-
1
-
-
62449248169
-
Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69, 593 and U50, 488 in rats
-
Baker L, Panos J, Killinger B, Peet M, Bell L, Haliw L, Walker S (2009) Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69, 593 and U50, 488 in rats. Psychopharmacology (Berl) 203:203-211
-
(2009)
Psychopharmacology (Berl)
, vol.203
, pp. 203-211
-
-
Baker, L.1
Panos, J.2
Killinger, B.3
Peet, M.4
Bell, L.5
Haliw, L.6
Walker, S.7
-
2
-
-
0026516004
-
9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication
-
9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci Biobehav Rev 16:55-62
-
(1992)
Neurosci Biobehav Rev
, vol.16
, pp. 55-62
-
-
Balster, R.L.1
Prescott, W.R.2
-
3
-
-
0028958518
-
Pharmacological, specificity of delta 9-tetrahydrocannabinol discrimination in rats
-
Barrett RL, Wiley JL, Balster RL, Martin BR (1995) Pharmacological, specificity of delta 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology (Berl) 118:419-424
-
(1995)
Psychopharmacology (Berl)
, vol.118
, pp. 419-424
-
-
Barrett, R.L.1
Wiley, J.L.2
Balster, R.L.3
Martin, B.R.4
-
4
-
-
33846799142
-
Hallucinatory and rewarding effect of salvinorin A in zebrafish: Kappa-opioid and CB1-cannabinoid receptor involvement
-
Braida D, Limonta V, Pegortai S, Zani A, Guertai-Rocco C, Gori E, Sala M (2007) Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement. Psychopharmacology (Berl) 190:441-448
-
(2007)
Psychopharmacology (Berl)
, vol.190
, pp. 441-448
-
-
Braida, D.1
Limonta, V.2
Pegortai, S.3
Zani, A.4
Guertai-Rocco, C.5
Gori, E.6
Sala, M.7
-
5
-
-
38049032934
-
Involvement of kappa-opioid and endocannabinoid system on salvinorin Ainduced reward
-
Braida D, Limonta V, Capurro V, Fadda P, Rubtao T, Mascia P, Zani A, Gori E, Fratta W, Parolaro D, Sala M (2008) Involvement of kappa-opioid and endocannabinoid system on salvinorin Ainduced reward Biol Psychiatry 63:286-292
-
(2008)
Biol Psychiatry
, vol.63
, pp. 286-292
-
-
Braida, D.1
Limonta, V.2
Capurro, V.3
Fadda, P.4
Rubtao, T.5
Mascia, P.6
Zani, A.7
Gori, E.8
Fratta, W.9
Parolaro, D.10
Sala, M.11
-
6
-
-
70350166693
-
Potential anxiolytic- And antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum in rodents
-
Braida D, Capurro V, Zani A, Rubtao T, Vigano D, Parolaro D, Sala M (2009) Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br J Pharmacol 157:844-853
-
(2009)
Br J Pharmacol
, vol.157
, pp. 844-853
-
-
Braida, D.1
Capurro, V.2
Zani, A.3
Rubtao, T.4
Vigano, D.5
Parolaro, D.6
Sala, M.7
-
7
-
-
1642340346
-
The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys
-
Butelman ER, Harris TJ, Kreek MJ (2004) The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology (Berl) 172:220-224
-
(2004)
Psychopharmacology (Berl)
, vol.172
, pp. 220-224
-
-
Butelman, E.R.1
Harris, T.J.2
Kreek, M.J.3
-
8
-
-
41149171838
-
Synthesis and in vitro opioid receptor functional, antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-(( 1 S)-1 - {[(3R, 4R)-4-(3-hydroxyphenyl)-3, 4-dimethyl-1 -piperidinyl ]methyl} -2-methylpropyl)-1, 2 3 4-tetrahydro-3-isoquinoltaecarboxamide (JDTic)
-
Cai TB, Zou Z, Thomas JB, Brieaddy L, Navarro HA, Carroll FI (2008) Synthesis and in vitro opioid receptor functional, antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-(( 1 S)-1 - {[(3R, 4R)-4-(3-hydroxyphenyl)-3, 4-dimethyl-1 -piperidinyl ]methyl} -2-methylpropyl)-1, 2, 3, 4-tetrahydro-3-isoquinoltaecarboxamide (JDTic). J Med Chem 51:1849-1860
-
(2008)
J Med Chem
, vol.51
, pp. 1849-1860
-
-
Cai, T.B.1
Zou, Z.2
Thomas, J.B.3
Brieaddy, L.4
Navarro, H.A.5
Carroll, F.I.6
-
9
-
-
54949096945
-
Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: Cross-talk between kappa-opioid and cannabinoid CB(I) receptors
-
Capasso R, Borrelli F, Caseio MG, Aviello G, Huben K, Zjawiony JK, Marini P, Romano B, Di Marzo V, Capasso F, Izzo AA (2008) Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(I) receptors. Br J Pharmacol 155:681-689
-
(2008)
Br J Pharmacol
, vol.155
, pp. 681-689
-
-
Capasso, R.1
Borrelli, F.2
Caseio, M.G.3
Aviello, G.4
Huben, K.5
Zjawiony, J.K.6
Marini, P.7
Romano, B.8
Di Marzo, V.9
Capasso, F.10
Izzo, A.A.11
-
10
-
-
4644244869
-
Pharmacological properties of JDTic a novel kappa-opioid receptor antagonist
-
Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard. JL, Pollard. GT, Aceto MD, Harris LS (2004) Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol 501:111-119
-
(2004)
Eur J Pharmacol
, vol.501
, pp. 111-119
-
-
Carroll, I.1
Thomas, J.B.2
Dykstra, L.A.3
Granger, A.L.4
Allen, R.M.5
Howard, J.L.6
Pollard, G.T.7
Aceto, M.D.8
Harris, L.S.9
-
11
-
-
29744441084
-
N-substituted cis-4a-(3hydroxyphenyl)-8a-methyloctahydroisoquinolines are opioid receptor pure antagonists
-
Carroll FI, Chaudhari S, Thomas JB, Mascarella SW, Gigstad. KM, Deschamps J, Navarro HA (2005) N-substituted cis-4a-(3hydroxyphenyl)-8a- methyloctahydroisoquinolines are opioid receptor pure antagonists. J Med Chem 48:8182-8193
-
(2005)
J Med Chem
, vol.48
, pp. 8182-8193
-
-
Carroll, F.I.1
Chaudhari, S.2
Thomas, J.B.3
Mascarella, S.W.4
Gigstad, K.M.5
Deschamps, J.6
Navarro, H.A.7
-
12
-
-
1342265861
-
Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist structural and functional considerations
-
Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ, Roth BL (2004) Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations. J Pharmacol Exp Ther 308:1197-1203
-
(2004)
J Pharmacol Exp Ther
, vol.308
, pp. 1197-1203
-
-
Chavkin, C.1
Sud, S.2
Jin, W.3
Stewart, J.4
Zjawiony, J.K.5
Siebert, D.J.6
Toth, B.A.7
Hufeisen, S.J.8
Roth, B.L.9
-
13
-
-
0015861774
-
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction
-
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
-
(1973)
Biochem Pharmacol
, vol.22
, pp. 3099-3108
-
-
Cheng, Y.1
Prusoff, W.H.2
-
14
-
-
33645088405
-
Activation of G-protetas ta brain by endogenous and exogenous cannabtaoids
-
Childers SR (2006) Activation of G-protetas ta brain by endogenous and exogenous cannabtaoids. AAPS J 8:E112-E207
-
(2006)
AAPS J
, vol.8
-
-
Childers, S.R.1
-
16
-
-
0036470141
-
Motivational effects of cannabtaoids are mediated by mu-opioid and kappa-opioid receptors
-
Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002) Motivational effects of cannabtaoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 22:1146-1154
-
(2002)
J Neurosci
, vol.22
, pp. 1146-1154
-
-
Ghozland, S.1
Matthes, H.W.2
Simonin, F.3
Filliol, D.4
Kieffer, B.L.5
Maldonado, R.6
-
17
-
-
0034648421
-
Salvia divinorum: An hallucinogenic mint which might become a new recreational drug in Switzerland
-
Giroud. C, Felber F, Augsburger M, Horisberger B, Rivier L, Mangin P (2000) Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland. Forensic Sei Int 112:143-150
-
(2000)
Forensic Sei Int
, vol.112
, pp. 143-150
-
-
Giroud, C.1
Felber, F.2
Augsburger, M.3
Horisberger, B.4
Rivier, L.5
Mangin, P.6
-
18
-
-
33749141262
-
Pattern of use and subjective effects of Salvia divinorum among recreational users
-
Gonzalez D, Riba J, Bouso JC, Gomez-J'arabo G, Barbanoj MJ (2006) Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend 85:157-162
-
(2006)
Drug Alcohol Depend
, vol.85
, pp. 157-162
-
-
Gonzalez, D.1
Riba, J.2
Bouso, J.C.3
Gomez-J'Arabo, G.4
Barbanoj, M.J.5
-
19
-
-
55949098666
-
Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase
-
Haller VL, Stevens DL, Welch SP (2008) Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. Eur J Pharmacol 600:50-58
-
(2008)
Eur J Pharmacol
, vol.600
, pp. 50-58
-
-
Haller, V.L.1
Stevens, D.L.2
Welch, S.P.3
-
20
-
-
0033739890
-
Cannabinoid and kappa opioid receptors.reduce potassium. K current via activation of G(s) proteins in cultured hippocampal neurons
-
Hampson RE, Mu J, Deadwyler SA (2000) Cannabinoid and kappa opioid receptors .reduce potassium. K current via activation of G(s) proteins in cultured hippocampal neurons. J Neurophysiol 84:2356-2364
-
(2000)
J Neurophysiol
, vol.84
, pp. 2356-2364
-
-
Hampson, R.E.1
Mu, J.2
Deadwyler, S.A.3
-
21
-
-
0025787612
-
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
-
Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40:471-478
-
(1991)
Pharmacol Biochem Behav
, vol.40
, pp. 471-478
-
-
Martin, B.R.1
Compton, D.R.2
Thomas, B.F.3
Prescott, W.R.4
Little, P.J.5
Razdan, R.K.6
Johnson, M.R.7
Melvin, L.S.8
Mechoulam, R.9
Ward, S.J.10
-
22
-
-
0003633755
-
-
National Research Council National Academy Press, Washington
-
National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington
-
(1996)
Guide for the Care and Use of Laboratory Animals
-
-
-
23
-
-
67650648706
-
Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter
-
Navarro HA, Howard JL, Pollard GT, Carroll FI (2009) Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter. Br J Pharmacol 156:1178-1184
-
(2009)
Br J Pharmacol
, vol.156
, pp. 1178-1184
-
-
Navarro, H.A.1
Howard, J.L.2
Pollard, G.T.3
Carroll, F.I.4
-
24
-
-
13344267870
-
Salvinorin, a new lransneoclerodane diterpene from Salvia divinorum (Labiatae)
-
Ortega A, Blount J, Manchand B (1982) Salvinorin, a new lransneoclerodane diterpene from Salvia divinorum (Labiatae). J Chem Soc Perkta Trans 1:2505-2508
-
(1982)
J Chem Soc Perkta Trans
, vol.1
, pp. 2505-2508
-
-
Ortega, A.1
Blount, J.2
Manchand, B.3
-
25
-
-
0037015067
-
Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist
-
Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 99:11934-11939
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 11934-11939
-
-
Roth, B.L.1
Baner, K.2
Westkaemper, R.3
Siebert, D.4
Rice, K.C.5
Steinberg, S.6
Ernsberger, P.7
Rothman, R.B.8
-
27
-
-
0030593443
-
Cannabinoid receptor stimulation of guanosine-5′-0-(3-[35S]thio) triphosphate binding in rat brain membranes
-
Selley DE, Stark S, Sim LJ, Childers SR. (1996) Cannabinoid receptor stimulation of guanosine-5′-0-(3-[35S]thio)triphosphate binding in rat brain membranes. Life Sci 59:659-668
-
(1996)
Life Sci
, vol.59
, pp. 659-668
-
-
Selley, D.E.1
Stark, S.2
Sim, L.J.3
Childers, S.R.4
-
28
-
-
0028305754
-
Salvia divinorum and salvinorin A new pharmacologic findings
-
Siebert DJ (1994) Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 43:53-56
-
(1994)
J Ethnopharmacol
, vol.43
, pp. 53-56
-
-
Siebert, D.J.1
-
29
-
-
0038017714
-
9- tetrahydrocannabinol-indueed antinociception in mice without altering other pharmacological effects
-
9-tetrahydrocannabinol-indueed antinociception in mice without altering other pharmacological effects. J Pharmacol Exp Ther 268:1381-1387
-
(1993)
J Pharmacol Exp Ther
, vol.268
, pp. 1381-1387
-
-
Smith, P.B.1
Welch, S.P.2
Martin, B.R.3
-
30
-
-
0028261433
-
Interactions between delta 9tetrahydrocannabtaol and kappa opioids in mice
-
Smith PB, Welch SP, Martin BR (1994) Interactions between delta 9tetrahydrocannabtaol and kappa opioids in mice. J Pharmacol Exp Ther 268:1381-1387
-
(1994)
J Pharmacol Exp Ther
, vol.268
, pp. 1381-1387
-
-
Smith, P.B.1
Welch, S.P.2
Martin, B.R.3
-
31
-
-
0031981037
-
Comparative receptor binding analyses of cannabinoid agonists and antagonists
-
Thomas BF, Gilliam AF, Burch DF, Roche MJ, Seltzman HH (1998) Comparative receptor binding analyses of cannabinoid agonists and antagonists. J Pharmacol Exp Ther 285:285-292
-
(1998)
J Pharmacol Exp Ther
, vol.285
, pp. 285-292
-
-
Thomas, B.F.1
Gilliam, A.F.2
Burch, D.F.3
Roche, M.J.4
Seltzman, H.H.5
-
32
-
-
23644444304
-
Synthesis of longchain amide analogs of the cannabinoid CB1 receptor antagonist N-(pipeiidtayl)-5-(4-chlorophenyl)-1 -(2 4-dichlorophenyl)-4- methyl1H-pyra zole-3-carboxaniide (SR141716) with unique binding selectivities and pharmacological activities
-
Thomas BF, Francisco ME, Seltzman HH, Thomas JB, Fix SE, Schulz AK, Gilliam AF, Pertwee RG, Stevenson LA (2005) Synthesis of longchain amide analogs of the cannabinoid CB1 receptor antagonist N-(pipeiidtayl)-5-(4-chlorophenyl)-1 -(2, 4-dichlorophenyl)-4-methyl1H-pyra zole-3-carboxaniide (SR141716) with unique binding selectivities and pharmacological activities. Bioorg Med Chem. 13:5463-5474
-
(2005)
Bioorg Med Chem.
, vol.13
, pp. 5463-5474
-
-
Thomas, B.F.1
Francisco, M.E.2
Seltzman, H.H.3
Thomas, J.B.4
Fix, S.E.5
Schulz, A.K.6
Gilliam, A.F.7
Pertwee, R.G.8
Stevenson, L.A.9
-
33
-
-
75749126604
-
Signal transduction of the CB1 cannabinoid receptor
-
Turu G, Hunyady L (2010) Signal transduction of the CB1 cannabinoid receptor. J Mol Endocrinol 44:75-85
-
(2010)
J Mol Endocrinol
, vol.44
, pp. 75-85
-
-
Turu, G.1
Hunyady, L.2
-
34
-
-
0028075329
-
Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divtaorta) A
-
Valdes LJ 3rd (1994) Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divtaorta) A. J Psychoactive Drugs 26:277-283
-
(1994)
J Psychoactive Drugs
, vol.26
, pp. 277-283
-
-
Valdes III, L.J.1
-
35
-
-
0020972613
-
Ethnopharmacology of ska Maria Pastora (Salvia divinorum, Epling and Jativa-M.)
-
Valdes LJ 3rd, Diaz JL, Paul AG (1983) Ethnopharmacology of ska Maria Pastora (Salvia divinorum, Epling and Jativa-M.). J Ethnopharmacol. 7:287-312
-
(1983)
J Ethnopharmacol
, vol.7
, pp. 287-312
-
-
Valdes III, L.J.1
Diaz, J.L.2
Paul, A.G.3
-
36
-
-
0021746557
-
Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint Salvia divinorum
-
Valdes LJ III, Butler WM, Hatfield. GM, Paul AG, Koreeda M (1984) Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum. J Org Chem 49:4716-4720
-
(1984)
J Org Chem
, vol.49
, pp. 4716-4720
-
-
Valdes III, L.J.1
Butler, W.M.2
Hatfield, G.M.3
Paul, A.G.4
Koreeda, M.5
-
37
-
-
67449168117
-
Discriminative stimulus properties of Delta9-tetrahydrocannabinol (THC) in C57B1/6 J mice
-
Vann RE, Warner JA, Bushell K, Huffman JW, Martin BR, Wiley JL (2009) Discriminative stimulus properties of Delta9-tetrahydrocannabinol (THC) in C57B1/6 J mice. Eur J Pharmacol 615:102-107
-
(2009)
Eur J Pharmacol
, vol.615
, pp. 102-107
-
-
Vann, R.E.1
Warner, J.A.2
Bushell, K.3
Huffman, J.W.4
Martin, B.R.5
Wiley, J.L.6
-
39
-
-
0032822969
-
Cannabis: Discrimination of internal bliss?
-
Wiley JL (1999) Cannabis: discrimination of "internal bliss"? Pharmacol Biochem Behav 64:257-260
-
(1999)
Pharmacol Biochem Behav
, vol.64
, pp. 257-260
-
-
Wiley, J.L.1
-
40
-
-
0038433333
-
Cannabinoid pharmacological properties common to other centrally acting drugs
-
Wiley JL, Martin BR (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471:185-193
-
(2003)
Eur J Pharmacol
, vol.471
, pp. 185-193
-
-
Wiley, J.L.1
Martin, B.R.2
-
41
-
-
21244434879
-
CB1 cannabinoid receptormediated modulation of food intake in mice
-
Wiley JL, Burston JJ, Leggett DC, Alekseeva OO, Razdan RK, Mahadevan A, Martin BR (2005) CB1 cannabinoid receptormediated modulation of food, intake in mice. Br J Pharmacol 145:293-300
-
(2005)
Br J Pharmacol
, vol.145
, pp. 293-300
-
-
Wiley, J.L.1
Burston, J.J.2
Leggett, D.C.3
Alekseeva, O.O.4
Razdan, R.K.5
Mahadevan, A.6
Martin, B.R.7
-
42
-
-
34548010555
-
The hallucinogen derived, from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats
-
Willmore-Fordham CB, Krall DM, McCurdy CR, Kinder DH (2007) The hallucinogen derived, from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats. Neuropharmacology 53:481-486
-
(2007)
Neuropharmacology
, vol.53
, pp. 481-486
-
-
Willmore-Fordham, C.B.1
Krall, D.M.2
McCurdy, C.R.3
Kinder, D.H.4
-
43
-
-
18744387407
-
Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: Agonist actions at kappa opioid receptors
-
Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ (2005) Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology (Berl) 179:551-558
-
(2005)
Psychopharmacology (Berl)
, vol.179
, pp. 551-558
-
-
Zhang, Y.1
Butelman, E.R.2
Schlussman, S.D.3
Ho, A.4
Kreek, M.J.5
|